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There are relatively few treatments that directly improve
outcome in critically ill patients. The mainstay of good inten-
sive care remains supportive therapy for failing organs
while strenuous attempts are made to avoid iatrogenic
damage and nosocomial infection. A number of recent
paper reports have focused on these last two areas.
Even an intervention as fundamental as intermittent posi-
tive pressure ventilation may be harmful if applied incor-
rectly and so the international consensus conference on
ventilator-associated lung injury (VLI) in acute respiratory
distress syndrome (ARDS) is timely. The animal data for
VLI is now compelling, but the evidence in humans neces-
sarily remains indirect. Nevertheless, the recently com-
pleted National Institutes of Health study has shown that
protective ventilation strategies can improve outcome. The
consensus conference also covers risk factors, incidence,
monitoring, morbidity and prevention of VLI.
Blood transfusion carries a small but quantifiable risk of
infection with HIV and other organisms. Since the average
transfusion requirement of intensive care unit (ICU)
patients is around three units per week, it was pertinent to
investigate whether recombinant human erythropoeitin
(rHuEPO) would reduce the volume of blood given to ICU
patients. Gettinger and colleagues demonstrated a cumu-
lative reduction, in transfused blood, of nearly 50% in ICU
patients treated with rHuEPO, but found no difference in
mortality or adverse events. Treatment with rHuEPO was
more expensive than blood transfusion, but in different
healthcare systems or with increasing scarcity of blood
this might not always be the case. Furthermore, the
medico-legal consequences of this finding are potentially
wide-ranging. Some Jehovah’s Witnesses admitted to the
ICU will demand treatment with rHUEPO, and the very
rare patient who becomes infected after blood transfusion
might in future ask what measures were taken to minimise
transfusion requirement.
Percutaneous tracheostomy is an example of an interven-
tion which carries a risk of harm but is nevertheless widely
perceived to be beneficial (despite the absence of data to
support improved outcomes). Escarment and colleagues
have published a case series of 162 patients, showing
that the risks of the Griggs technique are real but relatively
small, and no greater than those of the Ciaglia technique.
Martin and colleagues investigate the unusual axillary
approach to the central veins. Nearly 12% of patients
developed radiological evidence of venous thrombosis,
even though all received low molecular weight heparin.
This figure is similar to that reported following jugular vein
cannulation. The risk of thrombosis is greatest for patients
with catheters in situ more than 14 days and the authors
advise against long-term use of this site.
Three paper reports examine different aspects of nosoco-
mial infection. Vicca and colleagues ask the interesting
question of whether high nursing workload contributes to
methicillin resistant Staphylococcus aureus (MRSA)
spread in the ICU. The study was observational and only
50 patients with MRSA carriage were identified. Further
research is needed to confirm their plausible view that
staff shortages increase nosocomial infections.
Ventilator associated pneumonia (VAP) remains a major
problem for intubated ICU patients and the subject has
been comprehensively reviewed by Higgins. The impor-
tance of differentiating colonisation from infection and
the role of invasive procedures in diagnosis are covered
in detail. Interestingly, there have been no studies that
document improved outcome from VAP when invasive
techniques are used. Since fibreoptic bronchoscopy
adds some risk and considerable costs to the manage-
ment of ventilated patients, it cannot yet be recom-
mended for all patients.
The idea of giving supplemented oxygen to prevent surgi-
cal wound infections in patients having colo-rectal surgery
might seem too simple to be effective. However in a large
(500 patients) prospective randomised trial, Greif and col-
leagues have demonstrated a 50% reduction in wound
infections for patients given supplemented oxygen (80%
versus 30%) intra-operatively and for 2 h post-operatively.
There was no difference in length of hospital stay or mor-
tality. A subgroup analysis of only 30 patients showed no
adverse effect on pulmonary function or atelectasis in the
80% oxygen group. Despite this reassuring finding, morehttp://ccforum.com/paperreport
data are needed to establish beyond doubt that there are
no harmful pulmonary effects from such a high concentra-
tion of oxygen.
Noninvasive ventilation (NIV) is being used more frequently
since it was shown to be beneficial in patients with respira-
tory failure from chronic obstructive pulmonary disease
(COPD). Kilger et al used NIV in patients after early extuba-
tion, mainly following lung transplantation. They showed an
improvement in oxygenation and ventilatory parameters and
their results suggest that NIV may be a useful weaning tool.
Jolliet and colleagues studied patients with COPD and
compared NIV using a helium : oxygen mixture or oxygen-
enriched air. Impressively, they managed to avoid endotra-
cheal intubation in all 20 patients. NIV improved many
ventilatory parameters and there was a statistically signifi-
cant decrease in pCO2 and dyspnoea with the helium :
oxygen mixture. Larger numbers will be needed to deter-
mine whether there are any clinically significant benefits of
helium : oxygen mixture.
The wide variety of diagnoses in critically ill patients is a
constant challenge to the general intensive care physician
who needs to keep abreast of the latest advances in many
areas of medicine. The comprehensive review of unstable
angina by Yeghiazarians and colleagues is excellent in all
areas but deals particularly well with pathogenesis and the
role of new antiplatelet agents.
Viallon and colleagues address the use of intravenous
bicarbonate therapy in patients with diabetic ketoacidosis.
Although the study was retrospective, patients were well
matched for arterial pH. It is interesting that the time to pH
normalisation and urinary ketone clearance was the same
whether or not patients received bicarbonate.
Finally, Azoulay and colleagues have examined outcome in
75 patients with multiple myeloma admitted to their inten-
sive care unit between 1992 and 1998. In a multivariate
analysis, invasive mechanical ventilation and vasopressor
agents were associated with increased mortality and
disease remission with decreased mortality. Nevertheless,
20% of mechanically ventilated patients and 26% of
patients treated with vasopressors survived 30 days. Data
on medium and long-term survival would clearly have been
more informative. Arguably, it is unlikely that series such as
this will ever be able to offer definite admission criteria for
patients with poor prognoses — the case for sensitive
judgements by experienced, scientifically up to date clini-
cians remains as strong as ever.